☆ 4.4 Article

Anaplastic large cell lymphomas with equivocal DUSP22 FISH results: recommendations for clinical reporting and diagnostic evaluation

HUMAN PATHOLOGY (2023)

Related references

Note: Only part of the references are listed.

Article Hematology

DUSP22 rearrangement is associated with a distinctive immunophenotype but not outcome in patients with systemic ALK-negative anaplastic large cell lymphoma

Lianqun Qiu et al.

Summary: DUSP22 rearrangement is associated with systemic ALK-negative ALCL but recent study found that it is not associated with better clinical outcome. This study compared the clinicopathological features and outcomes of patients with ALK-negative ALCL with DUSP22 rearrangement (n=22) versus those without DUSP22 rearrangement (n=59). The survival rate of patients with DUSP22 rearrangement was not significantly different from those without DUSP22 rearrangement.

HAEMATOLOGICA (2023)

Add to Collection

Article Hematology

ALK-negative anaplastic large cell lymphoma with DUSP22 rearrangement has distinctive disease characteristics with better progression-free survival: a LYSA study

David Sibon et al.

Summary: ALK-negative anaplastic large cell lymphoma (ALCL) can be divided into subgroups based on DUSP22-R and TP63-R rearrangements. The presence of DUSP22-R is associated with a better prognosis and higher rates of bone involvement. DUSP22-R status significantly affects progression-free survival (PFS) but not overall survival (OS).

HAEMATOLOGICA (2023)

Add to Collection

Article Pathology

JAK/STAT3 Signaling Activation Related to Distinct Clinicopathologic Features in Systemic ALK- Anaplastic Large Cell Lymphomas New Insights into Their Heterogeneity

Jian-chao Wang et al.

Summary: This study aimed to explore the role of JAK/STAT3 signaling and its relationship with clinicopathologic features in ALK(-) ALCL. The results showed that p-STAT3(+) DN-ALCLs were a distinct subtype of ALK(-) ALCLs with unique morphological, phenotypical and clinical characteristics. Identifying ALK(-) ALCL subtypes by using p-STAT3 staining and DUSP22 rearrangement is a promising approach.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2023)

Add to Collection

Review Pathology

Classification and diagnostic evaluation of nodal T- and NK-cell lymphomas

Andrew L. Feldman et al.

Summary: This article discusses the classification and diagnostic evaluation of nodal T- and NK-cell lymphomas based on the 2022 International Consensus Classification of Mature Lymphoid Neoplasms (2022 ICC). It highlights the grouping of T-follicular helper cell lymphoma into a single entity with three subtypes, as well as the genetic subtype of ALK-negative anaplastic large cell lymphoma (ALCL) associated with DUSP22 rearrangement. The introduction of a new provisional entity, primary nodal EBV-positive T-/NK-cell lymphoma, is also mentioned, along with evolving molecular data indicating distinct subgroups within PTCL, NOS.

VIRCHOWS ARCHIV (2023)

Add to Collection

Article Hematology

The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee

Elias Campo et al.

Summary: Since 1994, the classification of lymphoid neoplasms has been continuously updated through international efforts, with recent progress driven by genomic studies. This proposal presents the International Consensus Classification of mature lymphoid, histiocytic, and dendritic cell tumors, which has refined diagnostic criteria and incorporated new insights from genomics.

BLOOD (2022)

Add to Collection

Letter Cell Biology

RNAseq identification of FISH-cryptic BCL6::TP63 rearrangement in ALK-negative anaplastic large-cell lymphoma

Nada Ahmed et al.

HISTOPATHOLOGY (2022)

Add to Collection

Article Pathology

Immunohistochemical Approach to Genetic Subtyping of Anaplastic Large Cell Lymphoma

Andrew L. Feldman et al.

Summary: Anaplastic large cell lymphoma (ALCL) can be genetically classified based on rearrangements of ALK, TP63, and/or DUSP22 genes. Immunohistochemistry can be used to detect fusion proteins and cytotoxic markers to predict DUSP22-A ALCL and DUSP22-R ALCL. An immunohistochemistry algorithm using ALK, LEF1, TIA1, and p63 markers can accurately subtype ALCL.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2022)

Add to Collection

Review Oncology

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms

Rita Alaggio et al.

Summary: This article provides an overview of the upcoming 5th edition of the World Health Organization classification of lymphoid tumors, highlighting changes from the previous edition such as reorganization of entities, modification of nomenclature, revision of diagnostic criteria, deletion of entities, introduction of new entities, and inclusion of tumor-like lesions.

LEUKEMIA (2022)

Add to Collection

Review Pathology

How I Diagnose Anaplastic Large Cell Lymphoma

Catalina Amador et al.

Summary: This review discusses the diagnosis of all 4 anaplastic large cell lymphoma (ALCL) entities, emphasizing the importance of a systematic approach and awareness of potential misdiagnosis. ALCLs are a group of mature T-cell lymphomas with CD30-positive characteristics, but they vary clinically and genetically. Special attention is needed for variant histology, clinical history, and antigenic aberrancies to accurately diagnose and subclassify ALCL.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2021)

Add to Collection

Letter Oncology

MYC break-apart FISH probe set reveals frequent unbalanced patterns of uncertain significance when evaluating aggressive B-cell lymphoma

Marie-France Gagnon et al.

BLOOD CANCER JOURNAL (2021)

Add to Collection

Article Anatomy & Morphology

ALK-Negative Anaplastic Large Cell Lymphoma (ALCL): Prognostic Implications of Molecular Subtyping and JAK-STAT Pathway

Mayur Parkhi et al.

Summary: Recent molecular studies on ALK-negative anaplastic large cell lymphoma (ALCL) have identified distinct subtypes based on DUSP22 rearrangements and TP63 expression, providing prognostic significance.

APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2021)

Add to Collection

Article Pathology

Striking Association of Lymphoid Enhancing Factor (LEF1) Overexpression and DUSP22 Rearrangements in Anaplastic Large Cell Lymphoma

Aishwarya Ravindran et al.

Summary: Anaplastic large cell lymphomas (ALCLs) are classified into ALK-positive and ALK-negative, with ALK-negative cases composed of DUSP22-rearranged, TP63-rearranged, and triple-negative cases. In ALCL, LEF1 expression is significantly higher in DUSP22-rearranged cases, indicating a distinct clinicopathologic subset. The strong and uniform LEF1 expression in ALCL has high predictive value for DUSP22 rearrangement, although it may not be involved in the Wnt/beta-catenin pathway.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2021)

Add to Collection

Review Oncology

Interstitial Deletions Generating Fusion Genes

Ioannis Panagopoulos et al.

Summary: Fusion genes are created by the physical joining of two different genes, often as a result of balanced chromosomal rearrangements such as translocations and inversions. Chromosome deletions, which are mostly submicroscopic and not detected by conventional cytogenetic analysis, also play a role in the formation of fusion genes. As tumors are increasingly analyzed using advanced techniques like array comparative genome hybridization (aCGH) and high throughput sequencing (HTS), more interstitial deletions giving rise to fusion genes are expected to be identified, with significant implications for cancer understanding and treatment.

CANCER GENOMICS & PROTEOMICS (2021)

Add to Collection

Article Pathology

Detection of cryptic CCND1 rearrangements in mantle cell lymphoma by next generation sequencing

Katarzyna Polonis et al.

ANNALS OF DIAGNOSTIC PATHOLOGY (2020)

Add to Collection

Letter Hematology

Identification of high-risk DUSP22-rearranged ALK-negative anaplastic large cell lymphoma

Greg Hapgood et al.

BRITISH JOURNAL OF HAEMATOLOGY (2019)

Add to Collection

Article Hematology

Recurrent MSCE116K mutations in ALK-negative anaplastic large cell lymphoma

Rebecca A. Luchtel et al.

BLOOD (2019)

Add to Collection

Article Hematology

The double-hit signature identifies double-hit diffuse large B-cell lymphoma with genetic events cryptic to FISH

Laura K. Hilton et al.

BLOOD (2019)

Add to Collection

Letter Hematology

DUSP22-rearranged anaplastic lymphomas are characterized by specific morphological features and a lack of cytotoxic and JAK/STAT surrogate markers

Arantza Onaindia et al.

HAEMATOLOGICA (2019)

Add to Collection

Article Hematology

Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with DUSP22 rearrangements

Rebecca A. Luchtel et al.

BLOOD (2018)

Add to Collection

Article Hematology

DUSP22 and TP63 rearrangements predict outcome of ALK-negative anaplastic large cell lymphoma: a Danish cohort study

Martin Bjerregard Pedersen et al.

BLOOD (2017)

Add to Collection

Article Pathology

Morphologic Features of ALK-negative Anaplastic Large Cell Lymphomas With DUSP22 Rearrangements

Rebecca L. King et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2015)

Add to Collection

Article Hematology

ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes

Edgardo R. Parrilla Castellar et al.

BLOOD (2014)

Add to Collection

Article Hematology

Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing

Andrew L. Feldman et al.

BLOOD (2011)

Add to Collection

Article Oncology

Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas

A. L. Feldman et al.

LEUKEMIA (2009)

Add to Collection

Article Genetics & Heredity

Cryptic deletions are a common finding in balanced'' reciprocal and complex chromosome rearrangements: A study of 59 patients

M. De Gregori et al.

JOURNAL OF MEDICAL GENETICS (2007)

Add to Collection

© Peeref 2019-2024. All rights reserved.